ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13819/30339_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67972/149849_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/2720/ihc_selected_60x60.jpg) | | ![](/images/14520/ihc_cell_selected_60x60.jpg) | ![](/images/2720/6690_B_8_1_rna_selected_60x60.jpg) | Mixed |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16629/37314_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50335/143981_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14488/33886_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images/13707/if_selected_60x60.jpg) | | ![](/images/13707/30523_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32017/139602_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45942/139631_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
DARC | Duffy blood group, atypical chemokine receptor | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17672/41563_B_8_2_rna_selected_60x60.jpg) | Mixed |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/13774/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13774/33100_B_8_2_rna_selected_60x60.jpg) | Mixed |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/27546/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/27546/61969_B_3_7_rna_selected_60x60.jpg) | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/25229/61162_A_3_1_rna_selected_60x60.jpg) | Mixed |
FZD1 | Frizzled family receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| ![](/images/13008/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/13008/32446_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
FZD10 | Frizzled family receptor 10 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/14484/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14484/34139_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
FZD3 | Frizzled family receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images/42320/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24995/57285_B_8_5_rna_selected_60x60.jpg) | Mixed |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13820/142579_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49244/122475_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
GPBAR1 | G protein-coupled bile acid receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62890/141592_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPR113 | G protein-coupled receptor 113 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44500/98191_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/42773/ihc_cell_selected_60x60.jpg) | ![](/images/42773/95049_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPR132 | G protein-coupled receptor 132 | G-protein coupled receptors Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/29694/65145_B_9_3_rna_selected_60x60.jpg) | Mixed |
GPR135 | G protein-coupled receptor 135 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45337/103484_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
GPR143 | G protein-coupled receptor 143 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3648/11322_B_7_3_rna_selected_60x60.jpg) | Mixed |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6970/19466_B_8_2_rna_selected_60x60.jpg) | Mixed |
GPR162 | G protein-coupled receptor 162 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | ![](/images/55135/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55135/130968_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
GPR17 | G protein-coupled receptor 17 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images/29766/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/29766/142591_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
GPR182 | G protein-coupled receptor 182 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27037/142398_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPR61 | G protein-coupled receptor 61 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images/26088/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26088/58703_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
GPR62 | G protein-coupled receptor 62 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31309/65396_B_9_5_rna_selected_60x60.jpg) | Tissue enriched |
GPRC5A | G protein-coupled receptor, family C, group 5, member A | G-protein coupled receptors Predicted membrane proteins
| ![](/images/20771/ihc_selected_60x60.jpg) | | | ![](/images/20771/47004_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/15247/37196_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
GRM1 | Glutamate receptor, metabotropic 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/15701/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15701/35577_B_7_4_rna_selected_60x60.jpg) | Group enriched |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/29740/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/29740/63005_B_9_5_rna_selected_60x60.jpg) | Mixed |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14011/142185_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12867/31386_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22708/53493_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
LGR6 | Leucine-rich repeat containing G protein-coupled receptor 6 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/8556/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/8556/23733_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
LHCGR | Luteinizing hormone/choriogonadotropin receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/9814/ihc_cell_selected_60x60.jpg) | ![](/images/9814/31107_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NMBR | Neuromedin B receptor | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| ![](/images/26825/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26825/60867_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/14509/ihc_cell_selected_60x60.jpg) | ![](/images/14509/34609_B_4_5_rna_selected_60x60.jpg) | Group enriched |
P2RY10 | Purinergic receptor P2Y, G-protein coupled, 10 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36757/74359_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14518/33943_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49047/111260_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PTAFR | Platelet-activating factor receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/27543/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/27543/62159_B_8_1_rna_selected_60x60.jpg) | Mixed |